Latest research report on “Peanut Allergy Therapeutics Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5614539
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
This report contains market size and forecasts of Peanut Allergy Therapeutics in Global, including the following market information:
Global Peanut Allergy Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peanut Allergy Therapeutics market was valued at 698 million in 2021 and is projected to reach US$ 5942.9 million by 2028, at a CAGR of 35.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epinephrine Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, J & J, Perrigo, GSK, Kaleo, Amneal Pharma and ALK Abello, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peanut Allergy Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peanut Allergy Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peanut Allergy Therapeutics Market Segment Percentages, by Type, 2021 (%)
– Epinephrine Injection
– Oral Immunotherapy
Global Peanut Allergy Therapeutics Market, by Distribution Channel, 2017-2022, 2023-2028 ($ millions)
Global Peanut Allergy Therapeutics Market Segment Percentages, by Distribution Channel, 2021 (%)
– Hospital Pharmacy
– Retail Pharmacy
Global Peanut Allergy Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peanut Allergy Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Peanut Allergy Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peanut Allergy Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– UCB Pharma
– J & J
– Amneal Pharma
– ALK Abello
– Aimmune Therapeutics
– HUAPONT Pharm
– Allergy Therapeutics
– ASIT Biotech
– DBV Technologies
– HAL Allergy
– Intrommune Therapeutics
More information about Discount offers (20% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5614539
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441